Lawsuits allege GLP-1s cause serious harm, but frequency is unclear
Key Takeaways
- Lawsuits allege GLP-1 drugs like Ozempic cause severe harm, including permanent blindness.
- Studies show a potential correlation between semaglutide and NAION, but causation remains unproven.
- Medical groups advise caution and note that existing data is insufficient to establish definitive risks.
- Millions of Americans use GLP-1 medications, making understanding their full side effect profile critical.
Lawsuits against GLP-1 drug manufacturers are highlighting concerns over serious adverse events, including permanent vision loss from NAION. Although millions of Americans use these medications for diabetes and weight loss, scant data makes it difficult to determine the exact frequency and direct causation of these rare complications. Medical organizations continue to study the issue while advising patients not to stop their treatments prematurely without consulting their physicians.
Recommended for you
Tools and services we trust to boost productivity and content workflows.
Browse picks